Bioscience

Biozona Weekly: New TGen clinic; Accelerate Diagnostics growth; DNA identification system

October 18, 2013

By Flinn Foundation

Convoy Therapeutics looks to raise $27 million
10/17/13 | Phoenix Business Journal | Angela Gonzales

Convoy Therapeutics, a biotech company focusing on skin treatments, is putting together a syndicate to raise $27 million that would be used to fuel the company’s growth.

TGen opens Center for Rare Childhood Disorders
10/15/13 | CBS 5 | Adam Longo

TGen opened the doors to the brand new Center for Rare Childhood Disorders, one of the world’s premier facilities for treating children with rare and life-threatening disorders, in downtown Phoenix.

Pima County supports rapid growth of biotech firm driving innovation in patient care
10/15/13 | TucsonCitizen.com | Staff Report

Growing startup biotech firm Accelerate Diagnostics is on track to meet all four employment benchmarks established when Pima County and the State of Arizona worked together in 2012 to lure the firm.

Miss Arizona champions TGen childhood center

10/15/13 | Arizona Republic | Submitted by Steve Yozwiak (TGen)

Miss Arizona, Jennifer Smestad, who battled Tourette’s Syndrome as a child, will support TGen and its efforts to help children overcome the difficulties they face with neurological disorders.

Venture West Awards Marketing of 535-Acre Tucson Business Park to CBRE

10/11/13 | Multi-Housing News Online | Balazs Szekely

Venture West awarded a team of six CBRE brokerage professionals with the marketing and leasing of the 535-acre business park that sits in the heart of Tucson’s bioscience region in Oro Valley.

Bioscience professor presents portable, speedy DNA identification system at Science Center
10/7/13 | Downtown Devil | Karla Liriano

Frederic Zenhausern, a researcher at the University of Arizona College of Medicine-Phoenix, has developed a breakthrough technology that brings the portrayal of forensic science on popular crime shows a little closer to reality.